Combination Gel and Vascular ND in Mild to Moderate Rosacea
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a single center, open-label, split-face, prospective study of ten to fifteen subjects
seeking vascular laser therapy for the treatment of mild to moderate rosacea. Subjects will
be screened for eligibility for vascular laser therapy outside of the confines of this
protocol. Once approved for laser, subjects will be screened for study enrollment and topical
treatment of their rosacea at the Screening/Baseline visit. All subjects will receive Finacea
15% gel and will be instructed to apply the study drug to one half of the face, twice daily.
Drug application will be modified just prior to and after the subjects' laser treatment to
reduce irritation. Subjects will undergo Vascular Nd:Yag laser therapy to involved areas over
the whole face two weeks after initiating Finacea treatment. Subjects will continue to use
Finacea gel to one half of the face for the duration of the study.